Dr. Nikola Ragusa, MD

Dr. Ragusa practices at New York Ophthalmology in New York, New York.

Dr. Ragusa's NPI, 1568625192, was assigned on July 3, 2008. Dr. Ragusa graduated from State University of New York Downstate Medical Center in 2006. Dr. Ragusa holds New York license 245591.

Dr. Ragusa's primary practice is New York Ophthalmology, at 8 Warren St, New York, NY 10007. The practice phone is (718) 585-5500.

Dr. Ragusa's primary practice is New York Ophthalmology in New York, New York. The medical group on file is Park South Medical. Dmand AI also links Dr. Ragusa to 3 more group practices and clinics, 3 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ragusa practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Ragusa's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Ragusa is licensed in New York.

CMS data shows 1,050 Medicare services from Dr. Ragusa across 16 procedure codes in 2024, for 241 Medicare patients. Medicare paid $76,033 for them.

CMS counts 241 Medicare patients who saw Dr. Ragusa in 2024. The largest group is 65 to 74, with 118 patients. 73% of them have high blood pressure, and 73% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ragusa's median patient age at 66, with 52% women.

In 2024, Dr. Ragusa wrote 4,857 Medicare Part D claims for 1,014 patients. 65% of them were for generic drugs. CMS names the drug for 4,749 of them, across 25 drugs with 11 or more claims each, at $705,612 in total drug cost. In 2023, CMS named 4,145 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Ragusa for performance year 2024, reported as part of a group. Dr. Ragusa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 57 procedures of cataract surgery by Dr. Ragusa, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Ragusa. Dr. Ragusa's most frequent co-authors are Robert Scott Feder, MD, Sadeer B. Hannush, MD and Carolyn Y. Shih, MD.

CMS Open Payments shows 331 general payments to Dr. Ragusa from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 43% of the total. Aerie Pharmaceuticals, Inc. paid the most, $50,939. It also lists 1 research payment totaling $1,808 in 2017.

Dr. Ragusa graduated from State University of New York Downstate Medical Center in 2006.